Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

United Therapeutics Grows With Drugs For Rare Diseases
Investors.com
Friday, February 4, 2011 - 11:37am
tags:
United Therapeutics, Remodulin, Adcirca, Tyvaso, PAH
Biodel leads biotech stocks lower
Marketwatch
Friday, February 4, 2011 - 11:35am
tags:
Biodel, biotech stocks, Linjeta, insulin
A.M. Vitals: Pfizer and Merck Diverge in a Tough Pharma World
WSJ Online
Friday, February 4, 2011 - 11:34am
tags:
Pfizer, Merck, patents
Feds Join Lawsuit Over Abbott Off-Label Marketing
Pharmalot
Friday, February 4, 2011 - 11:15am
tags:
off-label, Abbott Laboratories, whistleblowers, Depakote, DOJ
Alkermes Performs Better than Est.
Yahoo/Zacks.com
Friday, February 4, 2011 - 11:13am
tags:
earnings, Alkermes, JNJ
4-Star Stocks Poised to Pop: Momenta Pharmaceuticals
Motley Fool
Friday, February 4, 2011 - 11:12am
tags:
Momenta
Actelion Boss Won’t Give Up Without a Fight
WSJ Online
Friday, February 4, 2011 - 11:07am
tags:
Actelion
Bionor Will Conduct Further Trials of HIV Vaccine, CEO Says
Bloomberg
Friday, February 4, 2011 - 11:06am
tags:
Bionor Pharma, HIV, vaccines
Johnson & Johnson: Dividend Stock Analysis
Seeking Alpha
Friday, February 4, 2011 - 11:05am
tags:
JNJ, dividends
Galapagos, Merck Agree to End Strategic Alliances
Bloomberg
Friday, February 4, 2011 - 11:04am
tags:
Merck, Galapagos
Get Ready for Merck's Bumpy Ride
Motley Fool
Thursday, February 3, 2011 - 7:47pm
tags:
Merck
Merck CEO To Wall Street: Who Needs Guidance?
Pharmalot
Thursday, February 3, 2011 - 6:15pm
tags:
Merck, guidance, Pharma CEOs, Kenneth Frazier
Health Care Reform Cuts Into Sales: Glaxo CEO
CNBC
Thursday, February 3, 2011 - 6:13pm
tags:
GSK, healthcare reform, earnings, Andrew Witty
Legal costs behind Merck, GlaxoSmithKline losses in 4Q
Bizjournals.com
Thursday, February 3, 2011 - 6:12pm
tags:
legal, Merck, earnings, GSK
FDA Rejection Would Take Isis Stock Down
Seeking Alpha
Thursday, February 3, 2011 - 11:47am
tags:
FDA, mipomersen, Orexigen, Contrave, Isis Pharmaceuticals
Novo Nordisk Passes This Key Test
Motley Fool
Thursday, February 3, 2011 - 11:17am
tags:
Novo Nordisk
Allergan - Upgrades & Downgrades
TheStreet.com
Thursday, February 3, 2011 - 11:16am
tags:
Allergan
Optimer Gets NEJM Power
Forbes
Thursday, February 3, 2011 - 11:10am
tags:
New England Journal of Medicine, Optimer, fidaxomicin, Clostridium Difficile
Pfizer's Newest Acquisition Target
Motley Fool
Thursday, February 3, 2011 - 10:33am
tags:
Pfizer, M&A, Clinical Data, Dendreon, Amarin
Glaxo posts Q4 loss on Avandia charge
Yahoo/AP
Thursday, February 3, 2011 - 10:31am
tags:
GSK, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.